• Facebook
  • Twitter
  • Instagram
  • Youtube
  • LinkedIn
  • Take Action
  • Partner With Us
  • DONATE
National Consumers League
  • About NCL
    • About Us
    • Our Programs
    • Leadership
    • Trumpeter Awards
    • Legal Work
    • Careers
  • Our Work
    • Consumer Education
    • Consumer Protection
    • Food & Nutrition
    • Fraud Prevention
    • Health
    • Workers Rights
  • Where We Stand
    • Consumer Education
    • Consumer Protection
    • Fraud Prevention
    • Food & Nutrition
    • Health
    • Workers Rights
    • Other NCL Positions
  • Blog
  • Publications
    • Annual Report
    • Bulletin
    • Sign Up for Our Newsletters
  • Media
    • Press Releases
    • Podcast
    • NCL in the News
    • Keeping up with Sally & Staff
    • Media Toolkit
  • Contact
  • Search
  • Menu Menu
  • DONATE
  • About NCL
    • About Us
    • Our Programs
    • Leadership
    • Trumpeter Awards
    • Legal Work
    • Careers
  • Our Work
    • Fraud Prevention
    • Health
    • Food & Nutrition
    • Consumer Education
    • Workers Rights
    • Consumer Protection
  • Where We Stand
    • Fraud Prevention
    • Health
    • Food & Nutrition
    • Consumer Education
    • Workers Rights
    • Consumer Protection
  • Blog
  • Publications
    • Annual Report
    • Bulletin
    • Sign Up for Our Newsletters
  • Media
    • Podcast
    • NCL in the News
    • Press Releases
    • Keeping up with Sally & Staff
    • Media Toolkit
  • Contact
  • Take Action
  • Partner With Us

Consumer Education

NCL Consumer Education Policy

The following are the official policy statements, adopted by the Board of Directors, the governing body of the National Consumers League, which guide the advocacy work of the organization.

Knowledgeable consumers can participate more fully and effectively in the marketplace.  The more consumers know about their rights and responsibilities as well as about the goods and services they buy, the better they are able to protect themselves, make sound purchasing decisions, and contribute to the economy.  In the process of developing educational information for consumers, industry and government become more conscious of consumer needs, concerns, and interests, which can stimulate economic growth and underscore the changes needed to better serve consumers. In essence, consumer education can be the catalyst for changing individual behavior, strengthening enforcement of laws and regulations, developing alternatives when marketplace practices cannot be readily changed (as in a regulated market), and increasing effective citizen participation in the marketplace.

In an age of rapidly advancing technology, consumer education takes on an even more important role than in the past.  The proliferation of new markets, products, and services through the internet and other technology, creates the potential for large gaps in consumer knowledge and understanding and thus for marketplace abuse of unwary consumers.  Also, the ever-increasing amount of marketing directed at young people and children make the start of consumer education at an early age critical.

Children in a school setting are increasingly targets of advertising and other forms of marketing included in educational materials and programs.  NCL opposes this type of marketing to children in schools. Any corporate informational materials or programs in schools should be objective and stripped of all sales messages that are designed to impact or have the effect of influencing the purchasing behavior of children or their parents.

The United States is blessed with a diverse population.  It is to the benefit of consumers and the marketplace alike that consumer education comprehend this diversity and be structured in such a way as to ensure the inclusion of all people.

In subscribing to the principles outlined above, NCL supports the following to enable consumers to function effectively in the marketplace:

1. That educational resources be devoted to developing consumer education programs for kindergarten through graduate school, training teachers, developing adult courses and continuing education programs, and supporting community-based consumer education;

2. That federal, state, and local governments set goals for educating consumers and commit resources to implementing those goals;

3. That all providers of goods and services furnish consumer information at the point of purchase in a form that will be most easily understood by consumers, including alternate languages where appropriate; and

4. That business and labor develop and support relevant consumer information and education programs.

––Adopted December 13, 2000

Structured Settlements:  NCL has partnered with the American Association of People with Disabilities (AAPD) and the National Structured Settlements Trade Association (NSSTA) to promote legislation to protect personal injury settlements with Members of Congress on Capitol Hill.  NCL has worked to enact State Structured Settlement Protection Acts in states all across the Nation.  NCL worked with directly the Maryland State Attorney General to pass the Nation’s strongest and most effective SSPA and worked with the Washington, D.C. City Council to pass the first Structured Settlement Protection Act in the Nation’s Capitol. NCL has also partnered with nationally recognized consumer advocate Suze Orman to highlight the critical importance of smart and comprehensive settlement planning for injured people.

NCL Position Paper:  Structured Settlements:  Structured settlements enable seriously injured people and their families to live with economic security, dignity, independence, and freedom from reliance on government.  Structured settlements constitute a private sector funding alternative to taxpayer-financed assistance programs to meet the ongoing, long-term medical and basic living needs of seriously-injured persons and their families, providing long-term financial security through an assured stream of payments tailored to the injured person’s needs throughout his or her lifetime.  Thus, structured settlements enable seriously-injured people to live with dignity and financial independence, free from reliance on government programs and interference.  Click here  to read the full NCL position paper.  (Attachment #001)

NCL PTSD Issue Paper: Money Damages Recovered on Account of Post-Traumatic Stress Disorder Should Be Excluded from Gross Income Under IRC Section 104(a)(2).  Twenty Members on the House Ways and Means Committee have written to Treasury Secretary Yellen and IRS Commissioner to request the Internal Revenue Service (IRS) issue a revenue ruling clarifying that Post-Traumatic Stress Disorder (PTSD) and its related damages are physical injuries or sickness and excludable under Section 104(a)(2) of the Internal Revenue Code. PTSD was not recognized as a mental disorder by the American Psychiatric Association until 1980 but has been recognized as an illness affecting soldiers since the Civil War.  Not limited to soldiers, it affects men, women and children, soldiers and civilians alike, and left untreated, can result in permanent physical and cognitive disabilities and even death.

Under the current Tax Code, Section 104(a)(2) only provides tax exempt recoveries to victims of physical injuries or sickness.  In order to distinguish physical injuries from purely emotional distress type injuries, Congress amended Section 104(a)(2) of the Internal Revenue Code to require that for tax exemption, injuries or sickness must be physical in nature. The IRS later interpreted this to require the demonstration of some sort of observable harm. At the time, medical science was not sufficiently advanced to identify the structural damage done to the brain by PTSD. This remains the standard today.  Click here to read the full PTSD Issue Paper.  (Attachment #002)

NCL Position Paper:  Just the Facts about Structured Settlements Versus Factoring:  Structured settlements are a proven way for an injured party to receive compensation in a physical injury case.  A structured settlement is a stream of periodic payments paid to an injured party through the purchase of an annuity (fixed and determinable) issued directly by a highly rated life insurance company. Structured settlements provide physical injury victims with financial security through guaranteed long-term, income tax-free payments. Settlements designed to meet the needs of individual injury victims and their families are negotiated between claimants (or their guardians or other authorized representatives) and defendants (or their insurers) through their respective attorneys, each with the assistance of licensed brokers specially appointed by the life insurance companies.

NCL Promotes Fair Consumer Protections Against Factoring Abuses:  Sally Greenberg, NCL President stated, “All of us—structured settlement consultants, attorneys, judges, and consumer advocates and leaders in the disability rights community have a shared responsibility to help protect injured persons and people with disabilities from abusive and misleading financial practices.”  Structured settlements provide periodic payments over a long period of time and thereby provide personal injury claimants with long-term financial security.  The “factoring” of structured settlement payments, where finance companies purchase structured settlement payment streams at a discount, is problematic for several reasons including that these “factoring companies” pressure claimants to sell when there is no genuine need to sell, and because these factoring companies typically charge high discount rates and thereby pay only small amounts of money in exchange for a large amounts of future payments.  There are rare circumstances where a claimant may have a need to unwind a structured settlement, and if those circumstances present themselves, the key to a successful transaction is a fair and reasonable discount rate, and of course other fair and reasonable terms.  Unfortunately, most factoring transactions to not meet this standard.

NCL Supports Enactment of Structured Settlement Protection Acts in all 50 States and the District of Columbia:  New Hampshire now joins all 50 states and the District of Columbia with the recent enactment of the new NH Structured Settlements Protection Act. This is a major milestone achievement that would never have happened without the tireless leadership and support of the National Consumers League.  Thanks to NCL all 50 states and DC now have SSPA legal protections for people with structured settlements. This SSPA work has been accomplished state by state, starting in 1997 in Illinois with the steadfast commitment of consumer advocates, disability organization leaders and structured settlement industry leaders who made this happen.  NCL remains the most influential association dedicated to protecting the rights of people with structured settlements.

NCL Successfully Led the Fight for the Enactment of the Maryland Structured Settlements Protection:  Working with Maryland Attorney General Brian Frosh, Maryland State Court Officials and Maryland State Legislative Leaders, NCL helped produce the most effective consumer protections in the Nation against factoring abuses.  The Maryland Court of Appeals gave final approval to extensive new Rules of Practice and Procedure that will apply to all Maryland SSPA petitions.  The new rules, which have the force of law, were developed on an accelerated schedule in response to the Washington Post expose on factoring of lead poisoning settlements. Important highlights of Maryland Rules of Procedure Title 15, Chapter 1300 (Structured Settlement Transfers), Rules 15-1301 through 15-1307. Effective January 1, 2016 these new Rules:

  • Mandate that any SSPA petition involving a Maryland resident payee be filed in the Circuit Court for the county in which the payee resides.
  • Prohibit action on an SSPA petition in the absence of a hearing.
  • Require personal attendance at the hearing by the payee (unless the payee’s attendance is excused for good cause), the payee’s independent professional advisor and the petitioner or an officer or employee who can testify for the petitioner
  • Require that any petition under the Maryland SSPA include the following information:
    • A copy of the payee’s structured settlement agreement, a copy of annuity that funds the settlement (or, if an annuity is not available, a document from the annuity issuer or settlement obligor evidencing the annuity payments) and a copy of any court order approving the settlement.
    • Detailed written consent of the payee.
    • A detailed affidavit of the independent professional advisor who has advised the payee.
    • Salient information about the petitioner, including whether it is registered to do business in Maryland.
    • Information about prior transfers and attempted transfers involving the payee’s payment rights.
    • A statement whether “to the best of the petitioners knowledge…the structured settlement arose from a) a claim of lead poisoning, or b) any other claim in which an allegation was made in a court record of a mental or cognitive impairment on the part of the payee.

NCL Leadership Secures Passage of the First Ever Structured Settlements Protection Act in the District of Columbia:  In 2018, NCL led the fight for passage of the DC Structured Settlements Protection Act.  Thanks to the NCL leadership the DC Council Judiciary Committee and the full Council of the District of Columbia voted unanimously to support passage of the new DC Structured Settlements Protection Act of 2018. The District of Columbia will now join 50 states that have enacted such important legislation to enhance the protection of consumers who depend on structured settlements resulting from personal injuries.  It is NCL’s mission to ensure the rights of injured parties with respect to their structured settlements. The provisions included in the District of Columbia’s new SSPA are extremely beneficial to the long-term financial security of people with structured settlement annuities.  The new measures provide meaningful court protection, among other safeguards, for DC residents who might be contacted by factoring companies offering to buy out their annuities for pennies on the dollar. The Act assures that DC courts will have full information with which to make decisions on whether a proposed transfer is in the best interests of a given payee and their dependents.

NCL Applauds Warren Buffett’s Statement in Support of Structured Settlements:  Warren Buffett’s annual meeting has become one of the financial highlights for investors each year as tens of thousands attend in Omaha and millions watch online.  Recently, he highlighted the important work of trial attorneys and the necessity for them to protect their client’s financial recovery.  Mr. Buffett also emphasized the need for attorneys to offer their clients the option to structure a portion of their settlement.  There are many significant advantages to a personal injury claimant placing all or a portion of their legal settlement proceeds in a structured settlement, rather than accepting the entire settlement as a lump sum. Warren Buffett, Chairman of Berkshire Hathaway recently stated:

“Anyone settling a personal injury claim should seriously consider a structured settlement as part of their plan for financial recovery. Structured settlements can stretch settlement funds by providing tax-free payments for lost income, medical bills, or other future needs, which delivers tremendous long-term security for injured people and their families. Berkshire Hathaway is proud to be a leading provider of structured settlement annuities.”


What does Warren Buffett know about structured settlements, leading him to promote structured settlements publicly? He knows the following about structured settlements:

  • A structured settlement of a physical injury or workers compensation claim is tax-free.
  • A structured settlement can provide regular monthly, quarterly, bi-annual or annual

payments as well as intermittent lump sums (for example, to pay for a first house).

  • A structured settlement can provide life contingent income (income that cannot be outlived).
  • A structured settlement has a fixed rate of return. When markets crash, structured

settlements maintain their secure value.

  • Most traditional investments have ongoing overhead costs including management and administrative fees. Structured settlements do not.
  • A structured settlement protects settlement proceeds from being spent too quickly.
  • Where We Stand
  • Fraud Prevention
  • Health
  • Food & Nutrition
  • Consumer Education
  • Workers Rights
  • Consumer Protection
  • Our Impact

    The work of the National Consumers League is making a difference in people’s lives across the country. Meet some of the consumers touched by our programs.

    Read about NCL’s impact

  • Preventing yet another victim

    Paige, 55, a Nashville wife and mother of two, answered an employment ad for secret shoppers. Before sending payment to the scammers, she reached out to NCL.

    Read about NCL’s impact

  • Building a stronger generation

    A grease fire flared up in Decklan’s kitchen. As his family scrambled and panicked, fearing that the whole house might erupt in flames, Decklan remained calm. He hurried over to the pantry, grabbed some baking soda, and dumped it on the fire quickly extinguishing the blaze.

    Read about NCL’s impact

  • Script Your Future saved my life

    Cincinnati resident Charles, 45, lost his computer business — and health insurance— during a time of economic downturn. A diabetic, Charles was now unable to afford his medication. He stopped taking it which made him seriously ill and put his life at risk.

    Read about NCL’s impact

  • For a safer workplace

    Jeremy is a fast-food worker who has been employed at a number of Chipotle restaurants in New York City. When he was just 20 years old, he took part in an NCL research project that revealed that management practices within the fast food chain were putting workers—and food safety for customers—at risk.

    Read about NCL’s impact

  • Our Impact

  • Preventing yet another victim

  • Building a stronger generation

  • Script Your Future saved my life

  • For a safer workplace

Our Programs

About NCL

  • About Us
  • Our Programs
  • Leadership
  • Trumpeter Awards
  • Legal Work
  • Careers

Our Work

  • Fraud Prevention
  • Health
  • Food & Nutrition
  • Consumer Education
  • Workers Rights
  • Consumer Protection

Where We Stand

  • Fraud Prevention
  • Health
  • Food & Nutrition
  • Consumer Education
  • Workers Rights
  • Consumer Protection
  • Blog
  • Media
  • Privacy Policy

National Consumers League

DONATE
© Copyright - National Consumers League
Scroll to top

Sign Up for Fraud Alerts

Podcast Subscribe Form

"*" indicates required fields

Name*

Join the Campaign

"*" indicates required fields

Name*
ZIP / Postal Code*

PBPA Commends HHS Funding to Support Maternal and Infant Health

The Preterm Birth Prevention Alliance (PBPA), a coalition of maternal and women’s health advocates dedicated to improving preterm birth outcomes in the United States and addressing its disproportionate impact on women of color, applauds the U.S. Department of Health and Human Services (HHS) for awarding nearly $350 million to states across the country to improve support for safe pregnancies and healthy babies.

“For far too long, U.S. maternal health care has lagged behind that of other developed countries, particularly for women of color,” noted Sally Greenberg, Executive Director of the National Consumers League. “This additional funding will enable local health departments and nonprofits to better address the health care needs of the most vulnerable mothers and their babies.”

The funding, awarded by HHS’ Health Resources and Services Administration (HRSA), will support home visiting services, increase access to doulas, address infant mortality and maternal illness, and improve data reporting on maternal mortality.

“Maternal health care in the U.S. has consistently failed women of color,” Greenberg continued.  “We applaud HHS for this additional funding that will help to improve the maternal health for all mothers and babies, especially women of color and those most at-risk.”

The funding announcement follows the release of a report by the U.S. Commission on Civil Rights which found that Native American women are more than two times more likely to die from pregnancy-related complications than white women in the U.S. This disparity was further exacerbated for Black women in the U.S., who are three to four times more likely to die from pregnancy-related complications than white women.

“In addition to expanding programs to support maternal health, we must increase representation from racially and ethnically diverse groups in research and clinical trials, particularly those studying treatment options to prevent maternal morbidity and mortality,” said Greenberg.  “The need for the additional HHS funding and the report from the Commission on Civil Rights clearly illustrate how critical representative research and real world evidence are to ensuring all mothers and their babies have the same opportunity for the best possible health outcomes.”

Diverse research for a diverse America: The value of equitable, real-world research

August 12, 2021/in Blog, Health, Prevention Blog Post

By Sally Greenberg, NCL Executive Director

While the COVID-19 pandemic has led to hardship for all Americans, it is clear that people of color have been disproportionately burdened. Across the health care continuum, addressing this disparity has become part of the broader conversation about the history of systemic racism and the underlying social determinants of health that negatively affect the mental, physical, and economic health of individuals and entire communities.

The pandemic has underscored persistent health disparities, and there is growing recognition that representation in research and clinical trials can have a profound impact on health outcomes. A lack of representation from racially and ethnically diverse groups in research and clinical trials have typically led to gaps in data, missing the opportunity to assess the full impact of various treatments and drugs across a range of populations. The collection and use of real-world research and data to inform the potential use, risks, and benefits of medical products and treatments can ultimately lead to better health outcomes, particularly for those who have been underrepresented in the past.

Existing efforts to improve inclusion

Efforts to expand diversity and representation in medical research are underway in Congress. Policymakers are encouraging the incorporation of Real World Evidence (RWE) in drug development through the recent Cures 2.0 draft legislation released by Reps. Diana Degette (D-CO-1) and Fred Upton (D-MI-6). While the status quo limits us from effectively reaching underserved populations, the proposed legislation would allow studies that include RWE for some drugs after they have been approved. At the heart of this issue is a growing appreciation that the same therapy can affect different populations in different ways, which is why Cures 2.0 supports collecting data that more accurately reflects the unique experiences and needs of patients across diverse populations.

Recognizing the potential for RWE in maternal health

The lack of representative research in the field of maternal health is undeniable, and its implications are staggering. The dismal state of maternal care in the United States reflects how our health care system has failed women of color, including by not adequately studying treatment options to prevent maternal morbidity and mortality. The need for RWE is clear when you consider the persistent disparities in health outcomes that plague minority communities.

Preterm birth and its disproportionate impact on women of color is a stark illustration of the need to make progress on representative research in maternal health. Preterm birth is the second-largest contributor to infant death in America today. Despite the tremendous physical, emotional, and financial toll that preterm birth continues to take on our country — disproportionately so on women and families of color — not enough therapeutic tools currently exist to prevent it.

Today, “17P,” the only FDA-approved treatment to help reduce the likelihood of spontaneous, recurrent preterm birth in the United States is at-risk of being withdrawn from the market in all its forms, including the branded product and five generic versions. Unfortunately there is conflicting evidence from two different clinical trials, one representative of a diverse U.S. population and another studied in a largely white population in Europe. It’s not a straightforward comparison. If 17P is withdrawn, the women most affected by preterm birth, predominantly women of color, would be left without an FDA-approved treatment option.

The FDA is considering the path forward, including additional data collection through leveraging RWE from past patient use. The success of the first (approval) trial for 17P in the impacted communities signals the importance of RWE. Continued access to 17P is, at its core, a matter of health equity. Black women must not yet again be left vulnerable to a system that historically has overlooked them.

PRETERM BIRTH PREVENTION ALLIANCE APPLAUDS FDA’S GRANTING OF HEARING FOR THE ONLY FDA-APPROVED THERAPIES TO REDUCE RECURRENT PRETERM BIRTH

WASHINGTON, DC, August 26, 2021 –

Preterm Birth Prevention Alliance a coalition of maternal and women’s health advocates dedicated to improving preterm birth outcomes in the United States and addressing its disproportionate impact on women of color, commends the U.S. Food and Drug Administration (FDA) for granting a public hearing to discuss 17P, the only FDA-approved class of branded and generic treatments to reduce preterm birth in indicated patients.

We appreciate the FDA’s willingness to hear directly from individuals facing prematurity and the providers who treat them about their experiences with 17P,” said National Consumer League’s Executive Director Sally Greenberg. “It is an important step towards better understanding variations in efficacy across diverse populations and ensuring all women have an equal chance at the best possible outcomes.”

Last week, the FDA agreed to grant Covis Pharma, the manufacturer of the branded 17P product Makena its request for a public hearing to discuss 17P. Hydroxyprogesterone caproate—or “17P”—has been approved since 2011 and is the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth in the United States. In 2020, the FDA proposed withdrawing 17P in all its forms, including the branded product and its five generic versions, based on conflicting efficacy data from two studies composed of vastly different populations, one predominantly inclusive of women in the U.S. most vulnerable to preterm birth and one not.

“Mothers and birthing people deserve access to the best possible treatments to prevent preterm birth. We cannot achieve birth equity if we study pregnant women as a monolith,” said Blythe Thomas, Initiative Director of 1,000 Days. “It is only by systematically researching the real-world, post-market impact of 17P on individuals from a variety of racial and ethnic backgrounds, while maintaining access for all affected, that we can reduce disparities in maternal and infant health.”

While the hearing date has not yet been set, the Alliance looks forward to sharing the perspectives of affected individuals and their physicians with the agency once the hearing is scheduled and will continue to advocate for at-risk moms and babies of all races and ethnicities.

###

ABOUT THE PRETERM BIRTH PREVENTION ALLIANCE

The Preterm Birth Prevention Alliance (PBPA) is a coalition of maternal and women’s health advocates who share a common concern about the state of preterm birth in the United States and the proposed market withdrawal of 17P, the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth. Formed in 2021 by the National Consumers League, the 15 partners in the PBPA seek to improve preterm birth outcomes in the United States by maintaining access to safe, FDA-approved treatment options and advocating for more diverse medical research that adequately represents the experiences of women and newborns of color. Women of color need a seat at the table. To learn more, visit www.pretermbirthalliance.org

LEADING PATIENT ADVOCATES LAUNCH PRETERM BIRTH PREVENTION ALLIANCE TO PROTECT CRITICAL ACCESS TO THE SOLE FDA-APPROVED CLASS OF THERAPIES TO REDUCE RECURRENT PRETERM BIRTH

WASHINGTON, DC, April 20, 2021 – Today, the National Consumers League (NCL), along with a coalition of patient advocacy organizations dedicated to advancing the health of mothers and infants, announced the launch of the >Preterm Birth Prevention Alliance.

Members of the Alliance are joining forces in an effort to preserve patient access to the only Food & Drug Administration-approved class of treatments for pregnant women who have previously had an unexpected, or spontaneous, preterm birth. Together, Alliance members seek to ensure that the Food & Drug Administration (FDA) hears concerns from the full range of stakeholders about the potential risks and impact of withdrawal for at-risk pregnant women and their providers.

For the fifth year in a row, the U.S. preterm birth rate has increased (to 10.2 percent of births), and preterm birth and its complications were the second largest contributor to infant death across the country. Preterm birth also represents a significant racial health disparity, with Black women in America experiencing premature delivery at a rate 50 percent higher than other racial groups throughout the country.

However, in 2020, the FDA >proposed withdrawing hydroxyprogesterone caproate, commonly called “17P” or “17-OHPC”, the only FDA-approved class of branded and generic treatments to help prevent the risk of preterm birth in women with a history of spontaneous preterm birth. The FDA is currently determining whether to hold a hearing on the status of 17P, based on conflicting efficacy data from two studies composed of vastly different patient populations, one inclusive of women in the U.S. most vulnerable to preterm birth and one not.

“We’re fighting for a more inclusive healthcare system that gives everyone an equal chance to have the best outcomes possible,” said Sally Greenberg, executive director of the National Consumers League. “We don’t believe that removing 17P from the market without gaining a better understanding of who could benefit the most from its use is in the best interests of patients, nor their healthcare providers, particularly as there are no other approved treatment options available.”

To date, 14 organizations have joined NCL to advocate for the health interests of at-risk pregnant women and infants, including: 1,000 Days; 2020 Mom; American Association of Birth Centers; Black Mamas Matter Alliance; Black Women’s Health Imperative; Expecting Health; Healthy Mothers, Healthy Babies Montana; HealthyWomen; Miracle Babies; National Birth Equity Collaborative; National Black Midwives Alliance; National Partnership for Women & Families; Sidelines High-Risk National Support Network; and SisterReach.

“As a trained obstetrician and gynecologist, I know firsthand the impact of preterm birth on Black women and birthing people. I also know that racism – not race – is the driving factor leading the disproportionate impact of preterm birth on Black women and birthing people thereby exacerbating systemic inequities in maternal and infant health. To achieve birth equity, which is the assurance of the conditions of optimal births for all people with a willingness to address racial and social inequities in a sustained effort, we must work to protect and uphold a standard of care for spontaneous, recurrent preterm births and ensure it remains accessible and affordable for all who stand in need,” added Dr. Joia Crear Perry, founder and president of the National Birth Equity Collaborative.

The Preterm Birth Prevention Alliance is calling for the FDA to grant a public hearing to fully consider all of the data, additional research methods, and stakeholder perspectives before deciding whether to withdraw approval of this critical class of therapies. The health of America’s moms and babies warrants the utmost care and consideration.

###

ABOUT THE PRETERM BIRTH PREVENTION ALLIANCE

The Preterm Birth Prevention Alliance is a coalition of maternal and women’s health advocates who share a common concern about the state of preterm birth in the United States and the proposed market withdrawal of 17P, the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth. Formed in 2021 by the National Consumers League, we seek to improve preterm birth outcomes in the United States by maintaining access to safe, FDA-approved treatment options and advocating for more diverse medical research that adequately represents the experiences of women and newborns of color. Women of color need a seat at the table. To learn more, visit www.pretermbirthalliance.org.

Initial support for the Preterm Birth Prevention Alliance is provided by Covis Pharma.

MEDIA CONTACT:

Carol McKay, carolm@nclnet.org

<embed src=”https://art19.com/shows/ce489618-5918-423a-9b5f-35ce4c28ca09/episodes/2f8fa6fc-6aad-4f1f-bf13-3bdb0aa41732/embed?theme=light-custom&primary_color=%231850a3″ width=”100%” height=”300″></embed>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/c7b22520-c0aa-4718-9b59-4ee67e494547/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ab80228e-48d9-4a45-a894-a1bfc4e41c64/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ea08cbc0-f9f2-4082-9222-4e33f68b6826/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/5039453f-6008-413a-9f6b-c9be649fd26e/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/fafb46f8-6d90-4cd8-91be-616366d1b8ca/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/25f0485d-bbce-46c8-bb90-139dcf1a2e7b/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ffbcae35-84c5-4c8b-9686-6e2c79679dd0/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/520bdd73-d142-4508-9706-d81b5c042dff/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/12354e8b-bf15-4eba-b34f-20e435df3bb7/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>

<iframe src=”https://art19.com/shows/we-can-do-this/episodes/e2091efc-d66d-49f4-aa8e-8e6249858310/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>